Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Hung Lin

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Pathology|October 3, 2024
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockadePo-Hung Lin, Jason Yongsheng Chan, Peiyong Guan, et al.
Cancer Medicine|November 9, 2024
Nomogram Analysis for Predicting Response to Androgen-Receptor-Axis-Targeted Therapies in Patients With Metastatic Castration-Resistant Prostate CancerI-Hung Shao, Hsiang-Shen Wang, Chin-Hsuan Hsieh, et al.
Cancer Management and Research|November 17, 2022
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG DiscontinuationPo-Ting Lin, Ming-Li Hsieh, Shih-Huan Su, et al.
BMC Medical Imaging|February 26, 2025
Using deep learning to differentiate among histology renal tumor types in computed tomography scansHung-Cheng Kan, Po-Hung Lin, I-Hung Shao, et al.
Biomedicines|January 21, 2022
Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial CarcinomaChung-Ying Tsai, Hsiang-Cheng Chi, Ren-Chin Wu, et al.
Investigative and Clinical Urology|September 6, 2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancerChung-Lin Lee, Ying-Hsu Chang, Chung-Yi Liu, et al.
BMC Cancer|November 1, 2024
Integrating clinical and image-based parameters for prediction of early post-prostatectomy incontinence recovery: simplified nomogram approachI-Hung Shao, Sy-Yuan Chen, Hung-Yi Chen, et al.
Scientific Reports|August 1, 2024
No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomyTsu-Chen Lin, Guan-Heng Chen, Chin-Chung Yeh, et al.
Clinical Interventions in Aging|December 16, 2024
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser ProstatectomyPo-Han Chen, Ruei-Je Chang, Hsiang-Sheng Wang, et al.
Frontiers in Oncology|August 28, 2023
Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumorLiang-Kang Huang, Yu-Ching Lin, Hai-Hua Chuang, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|October 3, 2024
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockadePo-Hung Lin, Jason Yongsheng Chan, Peiyong Guan, et al.
Cancer Medicine|November 9, 2024
Nomogram Analysis for Predicting Response to Androgen-Receptor-Axis-Targeted Therapies in Patients With Metastatic Castration-Resistant Prostate CancerI-Hung Shao, Hsiang-Shen Wang, Chin-Hsuan Hsieh, et al.
Cancer Management and Research|November 17, 2022
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG DiscontinuationPo-Ting Lin, Ming-Li Hsieh, Shih-Huan Su, et al.
BMC Medical Imaging|February 26, 2025
Using deep learning to differentiate among histology renal tumor types in computed tomography scansHung-Cheng Kan, Po-Hung Lin, I-Hung Shao, et al.
Biomedicines|January 21, 2022
Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial CarcinomaChung-Ying Tsai, Hsiang-Cheng Chi, Ren-Chin Wu, et al.
Investigative and Clinical Urology|September 6, 2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancerChung-Lin Lee, Ying-Hsu Chang, Chung-Yi Liu, et al.
BMC Cancer|November 1, 2024
Integrating clinical and image-based parameters for prediction of early post-prostatectomy incontinence recovery: simplified nomogram approachI-Hung Shao, Sy-Yuan Chen, Hung-Yi Chen, et al.
Scientific Reports|August 1, 2024
No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomyTsu-Chen Lin, Guan-Heng Chen, Chin-Chung Yeh, et al.
Clinical Interventions in Aging|December 16, 2024
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser ProstatectomyPo-Han Chen, Ruei-Je Chang, Hsiang-Sheng Wang, et al.
Frontiers in Oncology|August 28, 2023
Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumorLiang-Kang Huang, Yu-Ching Lin, Hai-Hua Chuang, et al.
Pageof 8